Mesothelioma: all 475 studies
Page 4 of 5. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.
- Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural MesotheliomaTerminatedNCT02613299
- Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsCompletedNCT02611024Phase 1/2
- A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)Status unknownNCT02588131Phase 2
- Whey Protein Supplement in Combination With Physical Exercise and Nutrition ProgramCompletedNCT02585362Not applicable
- Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoStatus unknownNCT02580747Phase 1
- Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
- Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPMCompletedNCT02555007Phase 1
- 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)CompletedNCT02519049
- Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing DecorticationWithdrawnNCT02511600Phase 3
- Nivolumab in Patients With Recurrent Malignant MesotheliomaCompletedNCT02497508Phase 2
- Four Versus Six Cycles of Pemetrexed/Platinum for MPMStatus unknownNCT02497053Phase 2
- Isolated Thoracic Perfusion (ITP-F) for MPMCompletedNCT02467426
- Intrapleural Cryotherapy for Malignant Pleural MesotheliomaTerminatedNCT02464904Not applicable
- Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPMStatus unknownNCT02436733Phase 2
- TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma PatientsCompletedNCT02414945Phase 1/2
- Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive, not recruitingNCT02414269Phase 1/2
- Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)CompletedNCT02397928Phase 2
- Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma PatientsStatus unknownNCT02395679Phase 1
- Screening of Alberta Asbestos Exposed Workers for Lung Cancer and MesotheliomaTerminatedNCT02385812Phase 2
- A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant MesotheliomaTerminatedNCT02372227Phase 1
- MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLCCompletedNCT02369198Phase 1
- Clinical Trial of Intraperitoneal Hyperthermic ChemotherapyStatus unknownNCT02349958Phase 2
- Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural MesotheliomaCompletedNCT02303899Phase 2
- Observational Prospective Analysis of Biological Characteristics of Mesothelioma PatientsCompletedNCT02300883
- Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural MesotheliomaCompletedNCT02269878
- ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)CompletedNCT02194231Phase 2
- Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ MesotheliomaCompletedNCT02141347Phase 1
- Vinorelbine in MesotheliomaCompletedNCT02139904Phase 2
- Photodynamic Therapy During Surgery in Treating Patients With Pleural MalignancyWithdrawnNCT02106559Not applicable
- Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.CompletedNCT02078700Phase 2
- Study of the Glutaminase Inhibitor CB-839 in Solid TumorsCompletedNCT02071862Phase 1
- Study of the Combination of Tivantinib Plus Pemetrexed and CarboplatinCompletedNCT02049060Phase 1/2
- Mesothelioma and Radical Surgery 2Status unknownNCT02040272Not applicable
- Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and CisplatinTerminatedNCT02029690Phase 1
- Serum Biomarkers in Diagnosis of MesotheliomaCompletedNCT02029105
- Intrapleural AdV-tk Therapy in Patients With Malignant Pleural EffusionCompletedNCT01997190Phase 1
- Thromboelastography During Surgery for Malignant Pleural MesotheliomaStatus unknownNCT01912547
- Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung CancerTerminatedNCT01898156Phase 1/2
- Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural MesotheliomaTerminatedNCT01870609Phase 2
- Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural MesotheliomaStatus unknownNCT01869023Phase 2
- Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma PatientsCompletedNCT01865045
- Rapid Autopsy and Procurement of Cancer TissueTerminatedNCT01851395
- Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)CompletedNCT01812148
- The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural MesotheliomaCompletedNCT01776385Not applicable
- Clinical and Histopathologic Characteristics of BAP1 MutationsCompletedNCT01773655
- Validation of the MiCK AssayTerminatedNCT01770665
- A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate ChemotherapyTerminatedNCT01769547Phase 2
- Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and MesotheliomaCompletedNCT01766739Phase 1
- Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural MesotheliomaCompletedNCT01722149Early Phase 1
- Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.CompletedNCT01721018Phase 1/2
- Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to AsbestosStatus unknownNCT01719068
- The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant MesotheliomaStatus unknownNCT01655888Phase 2
- A Study of LY3023414 in Participants With Advanced CancerCompletedNCT01655225Phase 1
- A Clinical Study With Tremelimumab as Monotherapy in Malignant MesotheliomaStatus unknownNCT01649024Phase 2
- Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural MesotheliomaCompletedNCT01644994Phase 1/2
- Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma TreatmentSuspendedNCT01627795Phase 1/2
- PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural MesotheliomaTerminatedNCT01604005Phase 3
- Do Your Genes Put You at a Higher Risk of Developing MesotheliomaCompletedNCT01590472
- Ganetespib With Platinum, in Patients With Malignant Pleural MesotheliomaCompletedNCT01590160Phase 1/2
- A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural MesotheliomaStatus unknownNCT01569919Phase 2
- A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing CancersCompletedNCT01521325Phase 1
- Intrapleural Measles Virus Therapy in Patients With Malignant Pleural MesotheliomaCompletedNCT01503177Phase 1
- A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT01486368Phase 2
- SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural MesotheliomaTerminatedNCT01445392Phase 1
- Amatuximab for High Mesothelin CancersTerminatedNCT01413451Early Phase 1
- Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPMCompletedNCT01358084Phase 2
- Psychosocial Needs and Exploration of Online Support for Patients With MesotheliomaCompletedNCT01356251Not applicable
- Autologous Redirected RNA Meso-CIR T CellsCompletedNCT01355965Phase 1
- A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural MesotheliomaWithdrawnNCT01353482Phase 1/2
- Trimodality Therapy for Malignant Pleural MesotheliomaStatus unknownNCT01343264
- Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the BodyWithdrawnNCT01325753Not applicable
- Dendritic Cell Vaccination for Patients with Solid TumorsCompletedNCT01291420Phase 1/2
- Cisplatin With Alimta or Gemcitabine in Long Infusion for MesotheliomaStatus unknownNCT01281800Phase 2
- A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural MesotheliomaStatus unknownNCT01279967Phase 2
- Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasTerminatedNCT01258868Phase 1
- Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma TreatmentCompletedNCT01243632Phase 2
- Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant MesotheliomaCompletedNCT01241682Phase 1
- Intrapleural Gene Transfer for Pleural MesotheliomaCompletedNCT01212367Phase 1
- Standard Chemotherapy With of Without Axitinib in Malignant MesotheliomaCompletedNCT01211275Phase 1/2
- Pulmonary Interstitial Lymphography in Early Stage Lung CancerTerminatedNCT01188486Not applicable
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedNCT01143545Phase 1
- B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
- Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)CompletedNCT01134146Phase 1
- Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346Not applicable
- Combination Gene Transfer and ChemotherapyCompletedNCT01119664Phase 1
- AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaWithdrawnNCT01105390Phase 2
- A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.CompletedNCT00996567Phase 2
- Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal MesotheliomaStatus unknownNCT00996385Phase 2
- Response Evaluation in Malignant Pleural MesotheliomaStatus unknownNCT00969098
- Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial HyperplasiaStatus unknownNCT00899613
- Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107TerminatedNCT00898547
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or VermiculiteCompletedNCT00897247
- Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for MesotheliomaTerminatedNCT00895648Phase 2
- Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural MesotheliomaStatus unknownNCT00886028Phase 2
- Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) PatientsCompletedNCT00867711
- Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant MesotheliomaCompletedNCT00821860Phase 3
- Sorafenib in Previously Treated Malignant MesotheliomaStatus unknownNCT00794859Phase 2
- An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant MesotheliomaCompletedNCT00787410Phase 2
- CryoSpray Ablation(tm)Thoracic Patient RegistryWithdrawnNCT00785239